Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bio-marker Analysis Using Circulating Tumor Cells in Patients With Melanoma

NCT02828345 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.

NCT NCT02828345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02828345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bio-marker Analysis Using Circulating Tumor Cells in Patients With Melanoma
Lead sponsor
Abramson Cancer Center at Penn Medicine
Phase
Observational
Overall status
Withdrawn
Start date
November 30, 2013
Completion date
December 31, 2013
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma